Handelsbanken Fonder AB lessened its stake in shares of Itron, Inc. (NASDAQ:ITRI – Free Report) by 6.9% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 138,965 shares of the scientific and technical instruments company’s stock after selling 10,285 shares during the period. Handelsbanken Fonder AB’s holdings in Itron were worth $12,025,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in ITRI. Norges Bank purchased a new stake in shares of Itron in the fourth quarter worth $63,990,000. Soros Fund Management LLC purchased a new position in shares of Itron in the 4th quarter worth about $34,843,000. Millennium Management LLC boosted its stake in Itron by 269.3% in the 4th quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock worth $47,068,000 after purchasing an additional 369,617 shares in the last quarter. Merewether Investment Management LP grew its position in Itron by 1,552.7% during the 2nd quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock valued at $39,593,000 after purchasing an additional 282,587 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Itron by 20.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,536,081 shares of the scientific and technical instruments company’s stock valued at $137,659,000 after purchasing an additional 265,039 shares in the last quarter. 96.19% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several research analysts have issued reports on ITRI shares. TD Cowen decreased their target price on shares of Itron from $145.00 to $130.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Raymond James Financial began coverage on shares of Itron in a report on Tuesday, April 21st. They issued an “underperform” rating for the company. Stephens reiterated an “overweight” rating and set a $130.00 target price on shares of Itron in a research note on Wednesday, May 20th. Robert W. Baird set a $125.00 target price on Itron in a report on Wednesday, July 29th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Itron in a research note on Wednesday, August 5th. Eight analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $131.33.
Insider Buying and Selling at Itron
In related news, SVP Donald L. Reeves III sold 319 shares of Itron stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total value of $26,914.03. Following the completion of the sale, the senior vice president owned 29,100 shares of the company’s stock, valued at $2,455,167. The trade was a 1.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP John F. Marcolini sold 322 shares of the stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $27,167.14. Following the completion of the transaction, the senior vice president owned 24,689 shares in the company, valued at $2,083,010.93. This trade represents a 1.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 3,822 shares of company stock worth $314,303. Insiders own 1.77% of the company’s stock.
Itron Stock Performance
Shares of NASDAQ ITRI opened at $102.72 on Friday. The firm’s 50-day moving average price is $88.31 and its 200-day moving average price is $90.11. Itron, Inc. has a 52-week low of $77.77 and a 52-week high of $142.00. The company has a market cap of $4.50 billion, a PE ratio of 17.15, a PEG ratio of 0.84 and a beta of 1.30. The company has a quick ratio of 2.29, a current ratio of 2.75 and a debt-to-equity ratio of 0.96.
Itron (NASDAQ:ITRI – Get Free Report) last released its quarterly earnings data on Tuesday, July 28th. The scientific and technical instruments company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.29 by $0.30. Itron had a net margin of 11.90% and a return on equity of 19.26%. The firm had revenue of $562.90 million during the quarter, compared to analysts’ expectations of $566.34 million. During the same period in the previous year, the company earned $1.62 earnings per share. The firm’s quarterly revenue was down 7.2% on a year-over-year basis. Itron has set its Q3 2026 guidance at 1.500-1.600 EPS and its FY 2026 guidance at 6.300-6.500 EPS. As a group, analysts anticipate that Itron, Inc. will post 6.43 EPS for the current year.
Itron Profile
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
See Also
- Five stocks we like better than Itron
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRI – Free Report).
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
